Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results
Viking Therapeutics shares rose Monday morning before reversing course and declining after reporting the latest results from ...
clinicaltrialsarena4d
Viking stock fluctuates amid manufacturing concerns with obesity pill
Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.
Zacks.com on MSN22d
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
Going by the price/book ratio, the stock currently trades at 7.77, trailing 12-month book value, higher than 4.01 for the ...
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing ...
Kiplinger6d
Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data
It's been a volatile year for Viking Therapeutics stock, though good news on the weight-loss-drug front has the healthcare stock up 260% since the start of January. And Wall Street sees even more ...
Seeking Alpha5d
Viking stock drops 13% after jumping 9% on obesity drug data
Shares of Viking Therapeutics (NASDAQ:VKTX) fell 13% Monday afternoon after jumping 9% earlier in the day amid concerns that the company might face production problems for its promising weight ...